2,4-Dichloro-5-(trifluoromethyl)pyrimidine

We are 2,4-Dichloro-5-(trifluoromethyl)pyrimidine CAS:3932-97-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,4-Dichloro-5-(trifluoromethyl)pyrimidine
CAS.NO:3932-97-6
Synonyms:2,4-Dichloro-5-(trifluoromethyl)pyrimidine
2,4-Dichloro-5-trifluoromethylpyrimidine
 
Physical and Chemical Properties:
Density 1.6±0.1 g/cm3
Boiling Point 230.1±35.0 °C at 760 mmHg
Molecular Formula C5HCl2F3N2
Molecular Weight 216.976
Flash Point 93.0±25.9 °C
 
Specification:
Appearance:Colourless to light yellow liquid
Assay:≥98.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of CO-1686.

2,4-Dichloro-5-(trifluoromethyl)pyrimidine


Related News: The bulk-buy program, which currently covers 25 types of medicines, allows no more than three successful bidders access to China’s public hospitals, where most Chinese people buy their drugs.226915-53-3 The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.1-benzyl-4-chloropiperidine CAS:67848-71-9 The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.4-bromo-2-fluorobenzotrifluoruro CAS:142808-15-9 The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.

Related Products
Product Name
tert-butyl N-[(3S)-piperidin-3-yl]carbamate View Details
3-Nitrobenzotrifluoride View Details
1-Methyl-4-(4-piperidinyl)piperazine dihydrochloride View Details
4-Trifluoromethylbenzyl chloride manufacturer fluoranthen-3-amine manufacturer 2,4,6-Trichloroaniline manufacturer 3,5-Difluorophenol manufacturer 4-Isopropoxylphenylboronic acid manufacturer